OKYO Pharma Ltd
OKYO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001849296
In the last 90 days, OKYO Pharma Ltd insiders filed 7 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $9.74M in total; no superinvestor holds it.
Holders of 5% or more of OKYO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of OKYO Pharma Ltd, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Chernett Jorey | 13G/A | 9.50%3.80M shares | +1.70 ppfrom 7.80% | May 27, 20253 filings | Feb 13, 2026 | SEC |
| Sirenia Capital Management LP | 13G | 7.70%4.05M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
| Woodline Partners LP | 13G | 7.00%3.65M shares | New | May 15, 20261 filing | May 15, 2026 | SEC |
| Fonda Laura Natalia Monica | 13G | 5.01%1.93M shares | New | Oct 29, 20251 filing | Oct 29, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on OKYO Pharma Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20264:33 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 0.00%0 shares | −7.90 ppfrom 7.90%Below 5% | Mar 31, 2026 | SEC |
| May 15, 20269:01 AM ET | Woodline Partners LP | 13G | 7.00%3.65M shares | New | Mar 31, 2026 | SEC |
| May 15, 20268:02 AM ET | Sirenia Capital Management LPand 1 other | 13G | 7.70%4.05M shares | New | Mar 31, 2026 | SEC |
| Feb 18, 20265:42 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 7.90%4.06M shares | New | Feb 17, 2026 | SEC |
| Feb 13, 20265:08 PM ET | Chernett Jorey | 13G/A | 9.50%3.80M shares | +1.70 ppfrom 7.80% | Dec 31, 2025 | SEC |
| Feb 12, 20264:19 PM ET | Dauntless Investment Group, LLC | 13G/A | 1.20%471.5K shares | −5.10 ppfrom 6.30%Below 5% | Dec 31, 2025 | SEC |
| Nov 14, 202512:59 PM ET | Chernett Jorey | 13G/A | 7.80%2.98M shares | +1.00 ppfrom 6.80% | Sep 30, 2025 | SEC |
| Nov 14, 202512:50 PM ET | Dauntless Investment Group, LLC | 13G/A | 6.30%2.42M shares | −1.00 ppfrom 7.30% | Sep 30, 2025 | SEC |
| Oct 29, 20258:30 AM ET | Fonda Laura Natalia Monica | 13G | 5.01%1.93M shares | New | Jul 22, 2025 | SEC |
| Aug 5, 20253:22 PM ET | Dauntless Investment Group, LLC | 13G/A | 7.30%2.74M shares | +1.40 ppfrom 5.90% | Jun 30, 2025 | SEC |
| May 27, 20254:44 PM ET | Chernett Jorey | 13G | 6.80%2.30M shares | New | May 23, 2025 | SEC |
| Mar 18, 20252:35 PM ET | Dauntless Investment Group, LLC | 13G | 5.90%2.00M shares | New | Mar 12, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell OKYO Pharma Ltd shares.
No Form 144 notices for OKYO Pharma Ltd are on file.